Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.7400
0.00 (0.00%)
Feb 13, 2026, 3:49 PM HKT

HKG:3737 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
2,0072,2152,0501,8261,7471,604
Revenue Growth (YoY)
-1.81%8.05%12.26%4.55%8.89%19.50%
Cost of Revenue
870.03933.45835.21758.59685.15612.79
Gross Profit
1,1371,2811,2151,0671,061991.09
Selling, General & Admin
1,0491,094994.81914.57932.14790.58
Other Operating Expenses
65.1161.7255.449.2849.6459.4
Operating Expenses
1,1141,1561,050963.84981.77849.97
Operating Income
23.13125.14164.4103.5179.58141.12
Interest Expense
-5.57-6.99-7.87-6.56-7.08-5.22
Interest & Investment Income
4.695.27.0244.2210.08
Other Non Operating Income (Expenses)
28.132.7640.1926.5824.613.65
EBT Excluding Unusual Items
50.35156.1203.74127.53101.32159.63
Gain (Loss) on Sale of Investments
-8.42-9.753.412.43-39.617.81
Gain (Loss) on Sale of Assets
0.550.550.430.690.11-0.22
Pretax Income
42.48146.9207.58130.6561.81167.22
Income Tax Expense
21.7750.7543.4523.749.4528.6
Earnings From Continuing Operations
20.7196.15164.13106.9252.37138.62
Minority Interest in Earnings
-0.16-0.94-1.36-0.53-0.24-0.09
Net Income
20.5695.21162.78106.3952.13138.53
Net Income to Common
20.5695.21162.78106.3952.13138.53
Net Income Growth
-81.53%-41.51%53.00%104.09%-62.37%20.78%
Shares Outstanding (Basic)
844845847847837829
Shares Outstanding (Diluted)
844845847847837829
Shares Change (YoY)
-0.36%-0.18%-1.20%0.98%-0.69%
EPS (Basic)
0.020.110.190.130.060.17
EPS (Diluted)
0.020.110.190.130.060.17
EPS Growth
-83.96%-42.11%51.27%109.34%-64.10%21.45%
Free Cash Flow
133.6140.72-67.68196.17-7.47-20.81
Free Cash Flow Per Share
0.160.05-0.080.23-0.01-0.03
Dividend Per Share
0.0470.0470.0820.053-0.031
Dividend Growth
79.56%-42.49%53.92%---42.39%
Gross Margin
56.65%57.85%59.25%58.45%60.77%61.79%
Operating Margin
1.15%5.65%8.02%5.67%4.56%8.80%
Profit Margin
1.02%4.30%7.94%5.83%2.99%8.64%
Free Cash Flow Margin
6.66%1.84%-3.30%10.74%-0.43%-1.30%
EBITDA
71.68172.32215.3153.87119.71203.69
EBITDA Margin
3.57%7.78%10.50%8.43%6.85%12.70%
D&A For EBITDA
48.5547.1950.950.3740.1462.58
EBIT
23.13125.14164.4103.5179.58141.12
EBIT Margin
1.15%5.65%8.02%5.67%4.56%8.80%
Effective Tax Rate
51.24%34.55%20.93%18.17%15.28%17.11%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.